The early benefits of human papillomavirus vaccination on cervical dysplasia and anogenital warts

July 28, 2015

Source: PEDIATRICS, 2015, 135 (5), pp. 1131 – 1140

Follow this link for abstract

Date of publication: May 2015

Publication Type: Journal Article

In a nutshell: Background: Despite widespread promotion of quadrivalent human papillomavirus (qHPV) vaccination for young girls, there is limited information on the vaccine’s real-world effectiveness and none on the effectiveness of qHPV vaccination programs. We assessed the impact of the qHPV vaccine and Ontario’s grade 8 qHPV vaccination program on cervical dysplasia and anogenital warts (AGW)… Conclusions: This study provides strong evidence of the early benefits of qHPV vaccination among girls aged 14 to 17 years, offering additional justification for not delaying vaccination.

Length of publication: 9-page article

Advertisements

Minority girls less likely to have cervical cancer jab

November 25, 2013

Source: BBC News

Follow this link for full-text

Date of publication:

Publication Type: News

In a nutshell: Girls from black and Asian ethnic minorities are less likely to be vaccinated against cervical cancer, research suggests.

Length of publication: 1-page news story


Knowledge and awareness of HPV and the HPV vaccine among young women in the first routinely vaccinated cohort in England

February 6, 2013

Source: Vaccine, 2013, 31 (7), pp. 1051–1056

Follow this link for abstract

Date of publication: February 2013

Publication Type: Journal Article

In a nutshell: ► Little is known about HPV knowledge in vaccinated cohorts of girls in the UK. ► We surveyed girls in the first vaccinated cohort, three years after vaccination. ► Knowledge was low, with a fifth unaware of HPV. ► Many girls were unaware of the link between HPV infection and cervical cancer, and the need for cervical screening post-vaccination. ► There will be a need for targeted information when this cohort reaches screening age.

Length of publication: 5 page article


New cervical jab to be offered

September 6, 2012

Source: Nursing Times Online

Follow this link for abstract

Date of publication: September 2012

Publication Type: News Item

In a nutshell: Girls who are returning to school this week are being encouraged to ensure they receive all three doses of the cervical cancer jab.

Length of publication: 1 page news item

Some important information: Please contact your local NHS Library for the full text of the article. Follow this link to find your local NHS Library.


Survey of girls’ recall of a film providing information on human papillomavirus and cervical cancer 6 months after an offer of vaccination

May 5, 2010

Source: Vaccine, 2010 May 5 [Epub ahead of print]

Follow this link for abstract

Date of publication: May 2010

Publication Type: Journal Article

In a nutshell: Pre-adolescent girls who have been successfully immunised against human papillomavirus (HPV) may have relatively little knowledge about cervical cancer. A questionnaire was sent to 1084 girls approximately 6 months after they had been offered vaccination to assess whether an educational film had influenced their vaccine decision and what information they recalled. Girls who viewed the film were more likely to have wanted the vaccine than non-viewers (p = 0.015), but only 42% of them could recall details of the film 6 months later. Fear of cervical cancer may motivate young adolescents for vaccination but false assumptions might undermine later preventive actions by both the vaccinated and unvaccinated groups.

Length of publication: Unknown


Cervical cancer: problem solved? Vaccinating girls against human papillomavirus

April 6, 2010

Source: BJOG, 2010 Jan; 117 (2): 137-42

Follow this link for abstract

Year of publication: January 2010

Publication Type: Commentary

In a nutshell: September 2008 marked the beginning of a nationwide immunisation programme designed to protect British women against the devastating impact of cervical cancer. Cervarix™, a GlaxoSmithKline vaccine (Brentford, London, UK), offers protection against human papillomavirus (HPV) types 16 and 18, which together are responsible for approximately 70% of cervical cancers. In future, girls aged 12–13 years will be immunised each year as part of the routine National Health Service immunisation programme. In addition, all girls aged 13–18 years are being offered the vaccine in a one-off ‘catch-up’ programme. This will ensure that by 2011 the 12–18-years cohort will all have been invited for free HPV vaccination.

Length of publication: 6 page article


PCTs given £17m cancer immunisation fund

December 24, 2008

Source: Health Service Journal

For full text link here

Year of publication: 2008

Publication Type: News Story

In a nutshell: Primary care trusts are being handed up to £17m to carry out an anti-cancer immunisation programme for teenage girls two years ahead of schedule.

Further dissemination: If you think anyone would benefit from receiving this posting or from subscribing to this blog please email them the link to this blog and suggest they sign up to the blogs email newsletter to stay up-to-date with new content.